Cytomorphologic findings of low-grade fibromyxoid sarcoma.
Adolescent
Adult
Aged
Biomarkers, Tumor
/ analysis
Biopsy, Fine-Needle
Child
Cytodiagnosis
/ methods
Diagnosis, Differential
Female
Fibrosarcoma
/ diagnosis
Humans
Male
Middle Aged
Mucin-4
/ metabolism
Myxosarcoma
/ diagnosis
Neoplasm Grading
RNA-Binding Protein FUS
/ metabolism
Retrospective Studies
Soft Tissue Neoplasms
/ diagnosis
Young Adult
FUS rearrangement
Fine-needle aspiration biopsy
Low-grade fibromyxoid sarcoma
MUC4 immunohistochemical stain
Sarcoma
Journal
Journal of the American Society of Cytopathology
ISSN: 2213-2945
Titre abrégé: J Am Soc Cytopathol
Pays: United States
ID NLM: 101613234
Informations de publication
Date de publication:
Historique:
received:
30
12
2019
revised:
29
01
2020
accepted:
31
01
2020
pubmed:
22
3
2020
medline:
29
6
2021
entrez:
22
3
2020
Statut:
ppublish
Résumé
Low-grade fibromyxoid sarcoma (LGFMS) is a rare fibroblastic tumor characterized by a prolonged clinical course and malignant biological behavior. Given its deceptively bland cytomorphology, a diagnosis can be quite challenging notably on fine-needle aspiration (FNA). In an attempt to shed light on some of the distinctive cytomorphologic characteristics, this study was conducted to review all cases of LGFMS in our database, correlating available clinical data, immunohistochemical findings, and molecular analysis. This series included 20 FNAs from 18 patients with a histologically confirmed LGFMS diagnosis from 3 large academic institutions. Detailed cytomorphologic analysis for each case was documented in conjunction with corresponding clinical characteristics and provided ancillary testing. Out of 14 adequate FNA samples, 9 (64.2%) demonstrated a mixture of fibrous and myxoid pattern; the majority of cases were composed of deceptively bland tumor cells with rare nuclear pleomorphism and nuclear membrane irregularities. A MUC4 immunostain was performed on 5 specimens; all tested positive (100%). FUS rearrangement was detected in 4 out of 5 cases (80%). Follow-up information revealed 5-year recurrence in 1 case and metastatic disease in 2 cases, to the lung/pleura (8 years) and fourth rib (1 year), respectively. The presence of bland spindle cells and associated with myxoid matrix material, in the appropriate clinical setting, can suggest LGFMS and direct additional confirmatory testing. A definitive diagnosis of LGFMS on FNA requires adequate sampling, familiarity with key cytomorphologic features, acquisition of diagnostic material for a cell block preparation and ancillary testing, and clinicoradiologic correlation.
Identifiants
pubmed: 32197967
pii: S2213-2945(20)30033-8
doi: 10.1016/j.jasc.2020.01.006
pii:
doi:
Substances chimiques
Biomarkers, Tumor
0
MUC4 protein, human
0
Mucin-4
0
RNA-Binding Protein FUS
0
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
191-201Informations de copyright
Copyright © 2020 American Society of Cytopathology. Published by Elsevier Inc. All rights reserved.